معرفی
Angel Ruiz Moreno is a researcher at the University of Groningen with expertise in biochemistry, genetics, and molecular biology. His work contributes to multiple UN Sustainable Development Goals, particularly those related to health and well-being.
His research focuses on:
- Computational modeling of biological systems
- Small molecule drug discovery and development
- Gut microbiome analysis and metabolite prediction
- Cancer cell biology and therapeutic targeting
- Enzyme function and modulation
Ruiz Moreno's work integrates computational approaches with experimental validation to advance understanding of complex biological systems. His research spans gut microbiome dynamics, cancer therapeutics, and mitochondrial function, with a particular emphasis on small molecule interactions with biological targets. He has developed computational tools like MicrobeRX for metabolite prediction and has contributed to understanding host genetic regulation of gut microbial variation.
His publication in Nature (2024) on host genetic regulation of gut microbial structural variation has received significant attention with 68 citations, demonstrating the impact of his work. His research portfolio shows a consistent pattern of interdisciplinary collaboration across microbiology, pharmacology, and computational biology.
Ruiz Moreno actively collaborates with researchers across multiple institutions, as evidenced by his co-authorship on projects spanning microbiome research, cancer biology, and drug discovery. His six datasets related to experimental crystal structure determination demonstrate his contribution to structural biology research.
